GDGregory J. Dubel

Gregory J. Dubel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gregory J. Dubel has a total of 311 co-authors. Here are the top co-authors by number of shared publications:

  • Timothy P. Murphy

    Vascular Disease Research Center, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, United States

    3 shared publications
  • Gregory M. Soares

    Vascular Disease Research Center, Division of Vascular and Interventional Radiology, Department of Diagnostic Imaging, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, USA

    2 shared publications
  • Gregory Soares

    Department of Diagnostic Imaging, Division of Interventional Radiology, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island

    2 shared publications
  • Sun Ahn

    Department of Diagnostic Imaging, Division of Interventional Radiology, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island

    2 shared publications
  • Sun H Ahn

    2 shared publications
  • Aalpen A. Patel

    Department of Radiology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, One Silverstein, 3400 Spruce Street, Philadelphia, PA 19104, USA

    1 shared publication

Latest Publications

  • Prospective Margin Estimates Predict Local Tumor Progression Following Microwave Ablation of Small Renal Masses

    by Franklin Iheanacho, Nathaniel Rex, Karim Oueidat, Scott Collins, Grayson L. Baird, DaeHee Kim, Gregory J. Dubel, Bryan S. Jay, Aaron W. P. Maxwell

    Purpose To evaluate the relationship between prospectively generated ablative margin estimates and local tumor progression (LTP) among patients undergoing microwave ablation (MWA) of small renal masses (SRMs). Materials and Methods Between 2017 and 2020, patients who underwent MWA for SRM were retrospectively identified. During each procedure, segmented kidney and tumor shapes were coregistered with intraprocedural helical CT images obtained after microwave antenna placement. Predicted ablation zone shape and size were then overlaid onto the resultant model, and a model-to-model distance algorithm was employed to calculate multiple ablative margin estimates. LTP was modeled as a function of each margin estimate by hazard regression. Models were evaluated using hazard ratios and Akaike information criterion. Receiver operating characteristic curve area under the curve was also estimated using Harrell’s and Uno’s C indices (HI and UI, respectively). Results One hundred and twenty-eight patients were evaluated (median age 72.1 years). Mean tumor diameter was 2.4 ± 0.9 cm. LTP was observed in nine (7%) patients. Analysis showed that decreased estimated margin size as measured by first quartile (Q1; 25th percentile), maximum, and average ablative margin metrics was significantly associated with risk of LTP. For every one millimeter increase in Q1, maximum, and mean ablative margin, the hazard of LTP increased 67% (HR: 1.67; 95% CI = 1.25–2.20, UI = 0.93, HI = 0.77), 32% (HR: 1.32; 95% CI 1.09–1.60; UI = 0.93; HI = 0.76), and 48% (HR: 1.48; 95% CI 1.18–1.85; UI = 0.83; HI = 0.75), respectively. Conclusion Prospectively generated ablative margin estimates can be used to predict the risk of local tumor progression following microwave ablation of small renal masses. Level of Evidence 3 Retrospective cohort study. Graphical Abstract


  • Contemporary Endovascular Embolotherapy for Meningioma

    by Sun Ahn, Gregory Soares, Gregory Dubel

    Preoperative endovascular tumor embolization has been used for 40 years. Meningiomas are the most common benign intracranial tumor in which preoperative embolization has been most extensively described in the literature. Advocates of embolization report that it reduces operative blood-loss, and softens the tumor, thus making surgery safer and easier. Opponents suggest that it adds additional risk and cost for patients without controlled studies showing conclusive benefit. The literature suggests a 3 to 6% neurological complication rate related to embolization. The combined external and internal carotid artery blood supply and complex anastomoses of the meninges can make embolization challenging. Positive outcomes require thorough knowledge of the pertinent vascular anatomy, familiarity with the neurovascular equipment and embolics, and meticulous technique. There remains debate on several aspects of embolization, including tumors most appropriate for embolization, embolic agent of choice, ideal size of embolic, and the choice of vessel(s) to embolize. This detailed review of pertinent vascular anatomy, embolization technique, results, and complications should allow practitioners to maximize treatment outcomes in this setting.


  • Transcatheter Embolization in the Management of Epistaxis

    by Sun Ahn, Gregory Soares, Gregory Dubel

    A majority of the population will experience epistaxis at some time in their life. Most cases will be from an anterior source and can be treated with pressure, anterior nasal packing, or cautery. Intractable epistaxis is generally posterior in origin and may require endoscopic cautery, posterior packing, surgical ligation, or embolization. Embolization has been used to treat epistaxis for more than 30 years and success can be achieved in approximately 90% of patients, with major complications occurring in approximately 2%. These excellent results require thorough knowledge of the regional anatomy, familiarity with the equipment and various agents used to achieve this type of embolization, as well as attention to detail and meticulous technique. There remains debate on several aspects of embolization, including the agent of choice, preferred size of the embolic, and the number of vessels to embolize. Advances in endoscopic surgery have evolved to the point that similar success rates for embolization and modern surgical techniques in treating epistaxis may be expected. This detailed review of pertinent vascular anatomy, embolization technique, and surgical alternatives should allow practitioners to formulate treatment algorithms that result in optimal outcomes at their institutions.


  • Contributors

    by Hani Abujudeh, Andreas Adam, Hassan M. Ahmad, Sun Ho Ahn, Kamran Ahrar, Morvarid Alaghmand, Agaicha Alfidja, Ahmad I. Alomari, Gennaro Ambrosanio, Soon Ghee Ang, et al.

    • 1 December 2009
      • Vol. 92  (12) , 394-7

    Acute deep vein thrombosis (DVT): evolving treatment strategies and endovascular therapy.

    by Patrick Conklin, Gregory M Soares, Gregory J Dubel, Sun H Ahn, Timothy P Murphy

    DVT and PE contribute to at least 100,000 deaths each year. In addition, 4% of patients with PE will progress to CTEPH and PTS will affect nearly 30%. Anticoagulation alone appears inadequate to prevent PTS in many patients. Newer treatment strategies, including PCDT, appear to offer the possibility of reducing the pain, suffering and expense of PTS especially in the most severe cases. The NIH/NHLBI sponsored the ATTRACT trial, which will compare PCDT plus standard anticoagulation versus standard anticoagulation alone in patients with proximal DVT. The ATTRACT trial will enroll patients at both Miriam and RI Hospitals and is expected to add significantly to the research in this area. When successfully completed, results from the trial may guide therapy in the years ahead.


    • 1 December 2009
      • Vol. 92  (12) , 398-402

    Peripheral arterial disease: update of overview and treatment.

    by Todd C Schirmang, Sun H Ahn, Timothy P Murphy, Gregory J Dubel, Gregory M Soares


  • Regional Infusion-Radioembolization

    by Gregory J. Dubel, Gregory M. Soares


  • Open Access

    The role of percutaneous revascularization for renal artery stenosis

    by Gregory J Dubel, Timothy P Murphy

    Renal artery stenosis (RAS) is usually caused by atherosclerosis or fibromuscular dysplasia. RAS leads to activation of the renin-angiotensin-aldosterone system and may result in hypertension, ischemic nephropathy, left ventricular hypertrophy and congestive heart failure. Management options include medical therapy and revascularization procedures. Recent studies have shown angiotensin receptor blockers (ARB) and angiotensin converting enzyme inhibitors (ACE-I) to be highly effective in treating the hypertension associated with RAS and in reducing cardiovascular events; however, they do not correct the underlying RAS and loss of renal mass may continue. Renal artery angioplasty was first performed by Gruntzig in 1978. The routine use of stents has increased technical success rates compared with angioplasty, and surgery is now only rarely performed. Although numerous case series claimed benefit in terms of blood pressure control, no adequately powered randomized, controlled, prospective study of renal artery interventions has reported their effect on cardiovascular morbidity or mortality. The CORAL trial, an ongoing study of renal artery stent placement and optimal medical therapy (OMT) funded by the National Institutes of Health, is the first study to attempt to do so. Until the CORAL trial results are in, physicians will continue to be faced with difficult choices when determining the optimal management for RAS patients and deciding which, if any, patients should be offered revascularization.


  • Distal Embolic Protection for Renal Arterial Interventions

    by Gregory J. Dubel, Timothy P. Murphy

    Distal or embolic protection has intuitive appeal for its potential to prevent embolization of materials generated during interventional procedures. Distal protection devices (DPDs) have been most widely used in the coronary and carotid vascular beds, where they have demonstrated the ability to trap embolic materials and, in some cases, to reduce complications. Given the frequency of chronic kidney disease in patients with renal artery stenosis undergoing stent placement, it is reasonable to propose that these devices may play an important role in limiting distal embolization in the renal vasculature. Careful review of the literature reveals that atheroembolization does occur during renal arterial interventions, although it often goes undetected. Early experience with DPDs in the renal arteries in patients with suitable anatomy suggests retrieval of embolic materials in approximately 71% of cases and renal functional improvement/stabilization in 98% of cases. The combination of platelet inhibition and a DPD may provide even greater benefit. Given the critical importance of renal functional preservation, it follows that everything that can be done to prevent atheroembolism should be undertaken including the use of DPDs when anatomically feasible. The data available at this time support a beneficial role for these devices.


    • 1 June 2006
      • Vol. 89  (6) , 213-4

    Successful exclusion of abdominal aortic aneurysm using an endograft.

    by Gregory Dubel